Page last updated: 2024-08-24

fluorodeoxyglucose f18 and glyx-13 peptide

fluorodeoxyglucose f18 has been researched along with glyx-13 peptide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Miao, C; Sun, P; Wu, Q; Zhao, Y; Zhu, M1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and glyx-13 peptide

ArticleYear
Propofol Disrupts Aerobic Glycolysis in Colorectal Cancer Cells via Inactivation of the NMDAR-CAMKII-ERK Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:2

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colorectal Neoplasms; Dizocilpine Maleate; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Oligopeptides; Phosphoglycerate Kinase; Prognosis; Propofol; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2018